These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 874169)

  • 1. Radiopharmaceuticals for acutely damaged myocardium. II: Synthesis and evaluation of [203Hg] hydroxymercurifluoresceins.
    Hanson RN; Davis MA; Holman BL
    J Nucl Med; 1977 Aug; 18(8):803-8. PubMed ID: 874169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial infarct imaging agents. III. Synthesis and evaluation of [203Hg] hydroxymercuriphthaleins.
    Hanson RN; Davis MA; Holman BL
    J Nucl Med; 1977 Dec; 18(12):1211-4. PubMed ID: 203619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of radiopharmaceuticals sequestered by acutely damaged myocardium.
    Davis MA; Holman BL; Carmel AN
    J Nucl Med; 1976 Oct; 17(10):911-7. PubMed ID: 184259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uptake of 203Hg-hydroxy-mercury-fluorescein in myocardial infarcts.
    Ramanathan P; Ganatra RD; Daulatram K; Sen PK; Blau M
    J Nucl Med; 1971 Sep; 12(9):641-3. PubMed ID: 5571890
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial infarct imaging with technetium-labeled complexes.
    Holman BL; Davis MA; Hanson RN
    Semin Nucl Med; 1977 Jan; 7(1):29-35. PubMed ID: 189440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The scintigraphic demonstration of acute myocardial infarcts.
    Holman BL; Lesch M
    Compr Ther; 1976 Dec; 2(12):45-9. PubMed ID: 187370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthesis and chemical properties of 3-chloromercury-2-hydroxipropyl-urea.
    Berkes I; Jovanovic V; Zivanov-Stakić D
    Nucl Med (Stuttg); 1975 Dec; 14(4):374-80. PubMed ID: 1215214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor model studies of 131I-tetracycline and other compounds.
    Chauncey DM; Halpern SE; Hagan PL; Alazraki NP
    J Nucl Med; 1976 Apr; 17(4):274-81. PubMed ID: 1255253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and behaviour of various labelled mercury compounds in the organism. 3. Accumulation of mercuritetracycline, mercuric acetate and chlormerodrin in damaged muscle and tumour.
    Vavrejn B; Kronrád L; Petrboková I
    Radiobiol Radiother (Berl); 1973; 14(2):191-8. PubMed ID: 4725248
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue distribution studies with radioactive manganese: a potential agent for myocardial imaging.
    Chauncey DM; Schelbert HR; Halpern SE; Delano F; McKegney ML; Ashburn WL; Hagan PL
    J Nucl Med; 1977 Sep; 18(9):933-6. PubMed ID: 893794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 2,3-dimercaptopropionic acid on distribution and excretion of 115mCd and 203Hg in rats.
    Cikrt M; Tichy M; Jones MM
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):421-38. PubMed ID: 7163637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of parenterally administered 203Hg from the mouse tissues.
    Mehra M; Kanwar KC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):127-30. PubMed ID: 6520718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of the development of isoprenaline-induced heart lesions.
    Mráz M; Faltová E; Sedivý J; Protivová L; Pilný J
    Physiol Bohemoslov; 1980; 29(4):323-31. PubMed ID: 6448418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia.
    Málek P; Vavrejn B; Kolc J; Ratuský J
    Int J Clin Pharmacol; 1974 Dec; 10(4):266-72. PubMed ID: 4443131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Scintiscanning in myocardial infarct using "Mercuroscan"].
    Ballaira L
    Riv Crit Clin Med; 1968; 68():Suppl 6:947+. PubMed ID: 5747766
    [No Abstract]   [Full Text] [Related]  

  • 16. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.
    Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT
    J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and Carcinogenesis Studies of Mercuric Chloride (CAS No. 7487-94-7) in F344 Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Feb; 408():1-260. PubMed ID: 12621522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of a new diagnostic and antiarrhythmic agent, mercurascan, in experimental myocardial infarct].
    Malek P; Vavreĭn B; Kolts I; Vrana M; Ratuskiĭ I
    Eksp Khir Anesteziol; 1975; (6):3-11. PubMed ID: 1234540
    [No Abstract]   [Full Text] [Related]  

  • 19. Mercury 203 distribution in pregnant and nonpregnant rats following systemic infusions with thiol-containing amino acids.
    Aschner M; Clarkson TW
    Teratology; 1987 Dec; 36(3):321-8. PubMed ID: 3424221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed tumor uptake using chlormerodrin 203Hg.
    Zipf RE; Ralston L
    J Nucl Med; 1967 May; 8(5):360. PubMed ID: 6032660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.